XML 22 R11.htm IDEA: XBRL DOCUMENT
v3.7.0.1

Concentration of Credit Risk | 3 Months Ended
--- | ---
Mar. 31, 2017
Risks and Uncertainties [Abstract] |
Concentration of Credit Risk | Note 6 – Concentration of Credit Risk Cash and cash equivalents The Company maintains its cash and cash equivalents in banks insured by the Federal Deposit Insurance Corporation (FDIC) in accounts that at times may be in excess of the federally insured limit of $250,000 per bank. The Company minimizes this risk by placing its cash deposits with major financial institutions. At March 31, 2017 and December 31, 2016, the uninsured balances amounted to $1,255,907 and $2,038,985, respectively. Accounts receivable As of March 31, 2017, three customers accounted for 96% of the Company’s accounts receivable. As of December 31, 2016, three customers accounted for 91% of the Company’s accounts receivable. Major customers For the three months ended March 31, 2017, three customers accounted for approximately 39% of the Company’s net revenue. For the year ended December 31, 2016, three customers accounted for approximately 34% of the Company’s net revenues. Substantially all of the Company’s business is with companies in the United States. Major suppliers For the three months ended March 31, 2017 and the year ended December 31, 2016, our products were made by the following suppliers:
FOCUSfactor | Atrium Innovations - Pittsburgh, PA | Vit-Best Nutrition, Inc. - Tustin, CA
Flat Tummy Tea | Caraway Tea Company, LLC - Highland, NY | -
Neuragen | C-Care, LLC - Linthicum Heights, MD | -
UrgentRx | Capstone Nutrition - Ogden, UT | -
Hand MD | HealthSpecialty - Santa Fe Springs, CA |
Sneaky Vaunt | Dongguan Jingrui - China |
It is the opinion of management that the products can be produced by other manufacturers and the choice to utilize these suppliers is not a significant concentration.

X
- Definition The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -URI http://asc.fasb.org/topic&trid=2134479 + Details
Name: | us-gaap_ConcentrationRiskDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RisksAndUncertaintiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration